StonvexLoading…
StonvexStonvexStonvexCore line items from BYRN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-11-30 | Annual 2024 2024-11-30 | Annual 2023 2023-11-30 | Annual 2022 2022-11-30 |
|---|---|---|---|---|
Revenue | $118.12M | $85.76M | $42.64M | $48.04M |
Operating Income | $11.84M | $6.67M | $-7.79M | $-7.73M |
Net Income | $9.69M | $12.79M | $-8.19M | $-7.88M |
EPS (Diluted) | $0.40 | $0.55 | $-0.37 | $-0.35 |
Total Assets | $84.49M | $71.92M | $52.31M | $57.05M |
Total Liabilities | $18.73M | $17.55M | $9.99M | $11.05M |
Cash & Equivalents | $13.73M | $16.83M | $20.50M | $20.07M |
Free Cash Flow OCF − CapEx | $-9.20M | $9.39M | $2.99M | $-17.08M |
Shares Outstanding | 22.68M | 22.50M | 22.00M | 21.85M |